| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -26,280 | -13,730 | -70 | 4,410 | -30 |
| Net Income Growth | -91.41% | -19,514.28% | -101.59% | +14,800.49% | unch |
Tevogen Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Tevogen Inc. is a healthcare enterprise. The Company brings together complementary efforts Tevogen Bio, its biotechnology initiative; Tevogen.AI, its artificial intelligence and technology initiative and Tevogen Healthcare Services, its emerging healthcare services initiative. Tevogen Inc., formerly known as Tevogen Bio Holdings Inc., is based in WARREN, N.J.
Fiscal Year End Date: 12/31